• RNA-targeted drug market
• Therapeutic avenue delineation
• Target interactions and targetability
• Reverse translational models
• Optional RNA compatibility and/or solvation solutions
• Custom selection criteria
(synthesizability/specificity/bioavailability)
Precision interferometry for processive endoribonucleases
• HTS SPR
• HTS Cleavage UV/Vis kinetics also available
• HTS phenotypic screen in vivo
• Competitive costing
• Angiogenic model optimized
• Model design services available
Copyright © 2022 Azor Biotek - All Rights Reserved.